Martin Bornhäuser

Martin Bornhäuser is a clinical cancer researcher known for his focus on translating innovative cell-based treatment concepts into academic clinical trials. With a documented track record, he has made significant contributions to the field by bridging the gap between scientific discoveries and patient care. He is: Co-Speaker of Cluster4Excellence Saxocell amongst those. Moreover, he has held prestigious membership positions as the director of NCT/UCC Dresden. Martin Bornhäuser has been honoured as a DKFZ fellow and visiting Professor at King’s College, London. Notably, he has received the EBMT van Bekkum Award twice.